COLL Stock | Chart | Collegium Pharmaceutical Inc Stock Price Today, Chart, performance

Short Term Long Term Short Term Comparison Long Term Comparison

COLL
1d-0.63%
1w0.21%
1m21.94%
1y61.84%
COLL
1y61.84%
5y16.76%
10y0.00%
20y0.00%

Bitcoin
-3.80%
0.50%
37.29%
-40.23%
Bitcoin
-40.23%
105.95%
115,895.00%
0.00%

Ethereum
-4.66%
-3.79%
30.59%
-39.73%
Ethereum
-39.73%
35.04%
0.00%
0.00%

Gold
0.61%
0.67%
6.69%
8.77%
Gold
8.77%
45.39%
15.57%
426.72%

Silver
0.69%
1.29%
-1.06%
6.12%
Silver
6.12%
39.44%
-26.08%
388.40%

Apple
1.37%
3.42%
12.31%
-13.83%
Apple
-13.83%
267.65%
-68.06%
66,840.40%

Amazon
3.04%
4.84%
21.71%
-28.99%
Amazon
-28.99%
42.22%
-62.52%
9,271.22%

Microsoft
0.06%
2.30%
3.48%
-18.74%
Microsoft
-18.74%
184.15%
791.06%
1,543.61%

S&P 500
0.25%
1.26%
6.02%
-8.15%
S&P 500
-8.15%
44.22%
171.02%
381.95%

Dow & Jones
0.08%
1.04%
2.51%
-2.15%
Dow & Jones
-2.15%
30.30%
144.26%
327.66%

ATH

ATH Price$29.21
ATH Date2018-03-08
% since ATH-3.15%
% to ATH3.25%

ATL

ATL Price$7.59
ATL Date2017-05-08
% from ATL272.73%
Last Low Price$10.16
Last Low Date2019-07-22
% From Last Low178.44%

IPO

IPO Price$12.00
% Current ROI USD235.75%
ATH Price$29.21
% ROI ATH 38,484.85%

Graph takes few seconds to load...

Key Data

Current price	$28.29
Sector	Healthcare
Industry	Drug Manufacturers-Specialty & Generic
Today's High/Low	$28.6/$27.75
Volume	134,868.00
Previous Close	$28.47
52 Week High/Low	$30.22/$14.04
Market Cap	949,749,056.00
P/E Ratio	25.4865
Forward P/E 1 Yr.	$4.44
Earnings Per Share(EPS)	$1.94
Annualized Dividend	$0

$28.29

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment.
The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Annual Data \| Millions of US $ except per share data	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31
Cash on hand	$170.02	$146.63	$118.70	$153.23	$95.70	-	-
Receivables	$72.95	$77.95	$9.97	$2.13	-	$2.34	-
Inventory	$9.64	$7.82	$1.81	$1.32	$0	$1.32	-
Pre-Paid Expenses	-	-	-	-	-	-	-
Other Current Assets	$0.14	$1.01	$0.46	$0.30	$0.56	$0.53	$0.71
Total Current Assets	$255.72	$237.51	$133.48	$158.58	$96.88	$4.50	-
Property, Plant, And Equipment	$20.90	$9.27	$1.83	$1.04	$0.74	$0.51	$0.69
Long-Term Investments	-	-	-	-	-	-	-
Goodwill And Intangible Assets	-	-	$0	$0	$0	-	-
Other Long-Term Assets	$0.18	$0.20	$0.26	$0.30	$0.10	$0.08	$0.08
Total Long-Term Assets	$50.58	$53.73	$2.08	$3.44	-	-	-
Total Assets	$306.30	$291.25	$135.57	$162.02	$97.72	$5.09	$9.03
Total Current Liabilities	$201.77	$189.13	$31.49	$25.60	$8.43	$10.42	$2.62
Long Term Debt	$7.67	$9.86	$0	$1.48	$4.15	$6.81	$0.64
Other Non-Current Liabilities	-	$0.68	-	$0.03	$0.07	$0.10	$0.19
Total Long Term Liabilities	$17.11	$10.53	$0	$1.51	-	-	-
Total Liabilities	$218.87	$199.66	$31.49	$27.11	$12.65	$17.33	$3.45
Common Stock Net	$0.03	$0.03	$0.03	$0.03	$0.02	$0100000	$0100000
Retained Earnings (Accumulated Deficit)	$-359.90	$-337.18	$-298.05	$-223.18	$-129800000	$-101.75	-
Comprehensive Income	-	-	$0	$0	$0	-	-
Other Share Holders Equity	-	-	-	-	-	-	-
Share Holder Equity	$87.43	$91.59	$104.08	$134.91	$85.07	$-89.35	$5.58
Total Liabilities And Share Holders Equity	-	-	-	-	-	-	-

Annual Data | Millions of US $ except per share data

2019-12-31

2018-12-31

2017-12-31

2016-12-31

2015-12-31

2014-12-31

2013-12-31

Cash on hand

$170.02

$146.63

$118.70

$153.23

$95.70

Receivables

$72.95

$77.95

$9.97

$2.13

$2.34

Inventory

$9.64

$7.82

$1.81

$1.32

Pre-Paid Expenses

Other Current Assets

$0.14

$1.01

$0.46

$0.30

$0.56

$0.53

$0.71

Total Current Assets

$255.72

$237.51

$133.48

$158.58

$96.88

$4.50

Property, Plant, And Equipment

$20.90

$9.27

$1.83

$1.04

$0.74

$0.51

$0.69

Long-Term Investments

Goodwill And Intangible Assets

Other Long-Term Assets

$0.18

$0.20

$0.26

$0.30

$0.10

$0.08

Total Long-Term Assets

$50.58

$53.73

$2.08

$3.44

Total Assets

$306.30

$291.25

$135.57

$162.02

$97.72

$5.09

$9.03

Total Current Liabilities

$201.77

$189.13

$31.49

$25.60

$8.43

$10.42

$2.62

Long Term Debt

$7.67

$9.86

$1.48

$4.15

$6.81

$0.64

Other Non-Current Liabilities

$0.68

$0.03

$0.07

$0.10

$0.19

Total Long Term Liabilities

$17.11

$10.53

$1.51

Total Liabilities

$218.87

$199.66

$31.49

$27.11

$12.65

$17.33

$3.45

Common Stock Net

$0.03

$0.02

$0100000

Retained Earnings (Accumulated Deficit)

$-359.90

$-337.18

$-298.05

$-223.18

$-129800000

$-101.75

Comprehensive Income

Other Share Holders Equity

Share Holder Equity

$87.43

$91.59

$104.08

$134.91

$85.07

$-89.35

$5.58

Total Liabilities And Share Holders Equity

Annual Data \| Millions of US $ except per share data	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31
Revenue	$296.70	$280.41	$28.48	$1.71	$0	$0	-
Cost Of Goods Sold	$193.66	$165.68	$2.60	$0.21	$0	$0	-
Gross Profit	-	-	-	-	-	-	-
Research And Development Expenses	$10.34	$8.66	$8.57	$14.95	$7.98	$14.96	$14.16
SG&A Expenses	$116.45	$126.76	$92.76	$80.63	$18.93	$17.48	$15.87
Other Operating Income Or Expenses	-	-	-	-	-	-	-
Operating Expenses	$320.45	$301.10	$103.92	$95.79	$26.91	$17.67	-
Operating Income	$-23.75	$-20.69	$-75.45	$-94.08	$-26.91	$-17.67	-
Total Non-Operating Income/Expense	-	-	-	-	-	-	-
Pre-Tax Income	$-22.72	$-39.13	$-74.87	$-94.18	$-27.26	$-17.92	-
Income Taxes	-	$0	$0	$0	$0	$0	-
Income After Taxes	-	$0	$0	$0	$0	$0	-
Other Income	-	-	-	-	-	-	-
Income From Continuous Operations	$-22.72	$-39.13	$-74.87	$-94.18	$-27.26	$-17.92	-
Income From Discontinued Operations	-	-	-	-	-	-	-
Net Income	$-22.72	$-39.13	$-74.87	$-94.18	$-27.26	$-17.92	-
EBITDA	-	-	-	-	-	-	-
EBIT	$-23.75	$-20.69	$-75.45	$-94.08	$-26.91	$-17.67	-
Basic Shares Outstanding	-	-	-	-	-	-	-
Shares Outstanding	$33	$33	$30	$24	$14	$1	$2
Basic EPS	-	-	-	-	-	-	-
EPS - Earnings Per Share	-	-	-	-	-	-	-

Annual Data \| Millions of US $ except per share data	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31
Net Income/Loss	$-22.72	$-39.13	$-74.87	$-94.18	$-27.26	$-17.92	-
Total Depreciation And Amortization - Cash Flow	$15.48	$110.91	$0.59	$0.66	$0.17	$0.19	-
Change In Accounts Receivable	$4.99	$-68.23	$-7.84	$-2.13	$-2.13	$-2.13	-
Change In Inventories	$-1.83	$0.22	$-0.50	$-1.32	$-1.32	$-1.32	-
Cash Flow From Operating Activities	$27.78	$169.39	$-67.02	$-75.05	$-21.57	$-17.95	-
Cash Flow From Investing Activities	$-6.44	$-24.35	$-0.99	$-2.98	$-0.36	$-0800000	-
Debt Issuance/Retirement Net - Total	-	$-121.98	$-2.67	$-2.67	$-1.35	$11.97	-
Total Common And Preferred Stock Dividends Paid	-	-	$0	$0	$0	-	-
Financial Activities - Other	$-0.82	$-0.03	$-1.20	$-0.85	$-2.62	$-2.62	-
Cash Flow From Financial Activities	$2.04	$-117.20	$33.48	$135.56	$115.99	$12.04	$12.35
Net Cash Flow	$23.39	$27.84	$-34.53	$57.53	$94.06	$-5.92	-
Common Stock Dividends Paid	-	-	$0	$0	$0	-	-